22.02.2005 22:32:00

Unisys and GenuOne to Battle Pharmaceutical Counterfeiting Threats wit

Unisys and GenuOne to Battle Pharmaceutical Counterfeiting Threats with RFID-Enabled Product Tracking Solution


    Business Editors/Technology Editors

    BLUE BELL, Pa.--(BUSINESS WIRE)--Feb. 22, 2005--

Joint Approach Uses Anti-Counterfeiting, Track and Trace Technologies
    to Increase Security and Efficiency

    Unisys Corporation (NYSE:UIS) today announced that it has signed an agreement with Boston-based GenuOne, Inc., to help the healthcare and life sciences industries secure their supply chains. GenuOne is a leading provider of product tracking and authentication software.
    As part of the agreement, Unisys will leverage GenuOne software in its services to help clients meet imminent regulatory and retail mandates, as well as help clients address additional product safety initiatives and supply chain efficiency opportunities. The joint approach will include applications for electronic pedigree, diversion control and anti-counterfeiting. It is consistent with the federal Prescription Drug Marketing Act (PDMA) requirements and takes into consideration the Florida Laws, California requirements and the Model Rules of the National Association of Boards of Pharmacy (NABP).
    "The healthcare and life sciences industries are at a tipping point," said Todd Skrinar, a partner in Unisys Healthcare and Life Sciences practice. "Our clients believe that shrinking the gaps in the extended supply chain, while challenging, ultimately serves the best interest of all partners. They are looking for catalysts to help drive the transformation and we believe Unisys - with the addition of GenuOne's commercially deployed software - is in a unique position to be the driver behind this industry transformation."
    As a key component in the company's Global Visible Commerce strategy, the Unisys Guardian Framework supports a mixed environment of RFID technologies, smart barcodes, covert inks and other tagging methods. It integrates with existing enterprise systems that in many cases are not equipped to handle increasingly large volumes of data generated by new tracking technologies.
    The Unisys framework includes a portfolio of methods, models and applications for securing supply chains in the consumer product, retail and pharmaceutical industries. It is based on best practices Unisys has learned from over 10 years of experience in regulated environments.
    Unisys and GenuOne have integrated a pre-configured template of GenuOne's TraceGuard track and trace software into the Guardian Framework. The template acts as an accelerator for healthcare manufacturers, wholesalers and pharmacies as they pursue patient safety and brand protection initiatives utilizing electronic track and trace capabilities.
    "The market convergence of anti-counterfeiting, electronic pedigree and RFID mandates has created a unique opportunity for the life sciences industry to deploy a unified platform to address these issues," said Jeffrey Unger, CEO, GenuOne. "We are pleased to have been chosen by Unisys to be a part of its Guardian offering and are excited to expand our reach by partnering with a proven secure supply chain leader."

    About Unisys

    Unisys is a worldwide information technology services and solutions company. Our people combine expertise in consulting, systems integration, outsourcing, infrastructure and server technology with precision thinking and relentless execution to help clients, in more than 100 countries, quickly and efficiently achieve competitive advantage. For more information, visit www.unisys.com.

    About GenuOne, Inc.

    GenuOne (www.genuone.com) is the leading provider of product tracking software for visibility management. GenuOne's enterprise software enables companies to build and maintain a safe, secure and transparent supply chain. Its flagship product TraceGuard, is the RFID/Barcode infrastructure software to address product authentication, electronic pedigree tracking and asset tracking. Since its inception, GenuOne has tracked hundreds of millions of products across dozens of supply chains spanning more than 14 countries.

    RELEASE NO.: 0222/8512
    http://www.unisys.com/about__unisys/news_a_events/02228512.htm

    Unisys is a registered trademark of Unisys Corporation. All other brands and products referenced herein are acknowledged to be trademarks or registered trademarks of their respective holders.

--30--JO/ph*

CONTACT: Unisys Mike Maney, 215-986-2368 mike.maney@unisys.com or GenuOne, Inc. Alina Halloran, 617-226-3000 ahalloran@genuone.com

KEYWORD: MASSACHUSETTS PENNSYLVANIA INDUSTRY KEYWORD: HARDWARE PHARMACEUTICAL SOFTWARE NETWORKING PRODUCT MARKETING AGREEMENTS SOURCE: Unisys

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu Unisys Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Unisys Corp. 6,40 2,14% Unisys Corp.

Indizes in diesem Artikel

S&P 500 5 992,54 -0,79%
S&P 100 2 922,95 -0,95%